Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;24(2):e16697.
doi: 10.1111/jocd.16697. Epub 2024 Nov 21.

Cosmetic Dermatology in Patients With Immune-Mediated Skin Diseases: A Future Direction

Hanlin Zhang  1   2 , Keyun Tang  1   2 , Qiuning Sun  1   2
Affiliations

Cosmetic Dermatology in Patients With Immune-Mediated Skin Diseases: A Future Direction

Hanlin Zhang et al. J Cosmet Dermatol. 2025 Feb.
No abstract available

Keywords: atopic dermatitis; autoimmune blistering diseases; cosmetic dermatology; dermatology; immune‐mediated skin diseases; psoriasis; vitiligo.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. López E., Cabrera R., and Lecaros C., “Targeted Therapy for Immune Mediated Skin Diseases. What Should a Dermatologist Know?,” Anais Brasileiros de Dermatologia 99, no. 4 (2024): 546–567. - PMC - PubMed
    1. Chen A.‐J., Cai D.‐X., Chen X., et al., “Expert Consensus on the Treat‐To‐Target Strategy for Psoriasis With Biological Agents in China (Simplified Edition)#,” International Journal of Dermatology and Venereology 7, no. 2 (2024): 61–69.
    1. Zhang H., Yang Z., Tang K., Sun Q., and Jin H., “Stigmatization in Patients With Psoriasis: A Mini Review,” Frontiers in Immunology 12 (2021): 715839. - PMC - PubMed
    1. Zhang H., Yang L., Wang Y., et al., “Topical Calcineurin Inhibitors as a Double‐Edged Sword in Rosacea: A Systematic Review,” Journal of Cosmetic Dermatology 21, no. 4 (2022): 1695–1704. - PubMed
    1. Wu H., Zhang W., Wu Z., et al., “Observation of the Clinical Features of Dupilumab‐Associated Facial Erythema,” Postepy Dermatologii I Alergologii 40, no. 6 (2023): 741–746. - PMC - PubMed

LinkOut - more resources